Objectives -Inununological faecal occult blood testing has been recognised as a useful method for wide scale screening of colorectal cancer in Japan during the past few years. This study was carried out to evaluate the validity of an inununological faecal occult blood test for colorectal cancer screening. Methods -A screening progranune for colorectal cancer using an inununological faecal occult blood test was conducted on 3365 residents of regions within Nagano prefecture in 1991, and all the subjects were followed up for three years by verification from cancer registration. Based on the incidence of false negative cases among those who had been evaluated as normal by this screening, but were diagnosed as having colorectal cancer, the sensitivity and the specificity of this test were estimated. Results -Four false negative cases were found during the subsequent three year follow up period after screening. Among these four cases, one case was within the first follow up year, one case within the .second year, and two cases within the third year. Accordingly, the sensitivity of this test was calculated as 90.9% within one year, 83.3% within two years, and 71.4% within three years, while the specificity was found to be 95.6%, indicating a validity higher than that achieved by a chemical occult blood test. Conclusion -These findings suggest that the inununological faecal occult blood test has a high diagnostic accuracy and is a useful strategy for eolorectal cancer screening.
In Japan the immunological faecal occult blood test has become established as an effective means for colorectal cancer screening."? Over the past 10 years about 20 types of immunological faecal occult blood test kits have been developed, and various reports have asserted the usefulness of this test as a colorectal cancer screening method.
For a routine screening test, high sensitivity and specificity are essential.' To assess the accuracy of immunological faecal occult blood testing for colorectal diagnosis these values must be determined.
We previously reported the high diagnostic accuracy of this test, compared with a conventional chemical test, such as Haemoccult II, based on the results of diagnosis with this test in patients with colorectal cancer and healthy controls as well as the results of mass screening for colorectal cancer using this rest.' For this study we re-evaluated the validity of the immunological faecal occult blood test in mass screening for colorectal cancer using a three year follow up period for all subjects.
Methods
The screening examination for colorectal cancer was conducted in the farming regions within Nagano prefecture in 1991. Subjects who had already been screened were excluded from the study. The subjects were over the age of 40 and mainly asymptomatic. Each subject received an immunological faecal occult blood test using a one day method without dietary restriction. Any subjects found to be positive were examined either by colonoscopy or, in 2% of cases, by barium enema.
As a further test of diagnostic accuracy, all the test subjects were followed up for three years by verification from records (cancer registration) of patients with colorectal cancer. We defined a false negative as those people who were diagnosed with colorectal cancer within one year, two years, and three years of a negative result from a faecal occult blood test. We then estimated the sensitivity and the specificity of the test from the incidence of these false negative cases.
The principles and procedures of the immunological slide Monohaem (Nihon Pharmaceutical, Japan), which was used in the screening programme, are as follows. Firstly, those being screened are asked to make a thin faecal smear on the test filter paper. Ifhuman haemoglobin is present in the faecal sample it will participate in an antigen-antibody reaction with the monoclonal antibody in the filter paper. The reacted sample is then washed to remove components other than haemoglobin, and a colour coupler is added. Oxygen is dissociated from hydrogen peroxide by the peroxidase-like activity of the human haemoglobin, which oxidises tetramethylbenzidine, leading to the -appearance of a green colour. The presence of human haemoglobin is thus indicated by the appearance of this green coloration. The procedures of this test are uncomplicated and the cost per slide for each test is about $2.50. The feasibility of carrying out a study by this desirable method on a large scale is poor owing to the operational difficulties and ethical problems, and thus a follow up study after screening an asymptomatic population is recommended as the next best means of investigating the validity of this screening test.' The sensitivity of the immunological occult blood test in our study was 91 % and the specificity 96% during a one year follow up period. The sensitivity is higher and the specificity is almost equal to the values obtained from the above described srudies'" as well as other follow up studies using the guaiac-based test,":" indicating that the immunological test is more accurate than chemical tests.
A retrospective study of patients with colorectal cancer also provides information about the accuracy of a screening test, and some studies with this design have been reported. [13] [14] [15] [16] [17] Such investigations have a limitation, however, because of the characteristics of the study subjects -that is, symptomatic patients and patients with cancer. The values obtained for the sensitivity and the specificity will be affected by the definition of false negativity. A generally accepted definition of false negativity is those cases who are diagnosed with colorectal cancer within one year of a negative result from a faecal occult blood test. However, there is no clear understanding of the natural history of colorectal cancer and no direct evidence to show how much earlier the detectable preclinical phase cancer occurred before screening. For this reason we used three definitions of false negativity, according to the length of follow up, to calculate the sensitivity and the specificity.
Thomas et al reported a test sensitivity of 68% based on the results of a two year follow up after screening using a chemical test, IS Table 1 shows the number of participants in the screening programme by sex and age cohort. The female to male ratio was 1.1 and the age distribution did not differ by sex. The screen compliance was 84.5% (3365/3982). The screening programme for colorectal cancer identified 157 people among the 3365 subjects (4.7%) with a positive occult blood test result. Among theses 157 positive cases (examination compliance 100%), 10 were found subsequently to have cancer and 43 had a polyp.
Results
The detection rates of these patients with . cancer and polyp among the total screening population was 0.30% and 1.28%, respectively, equivalent to detection rates of 6.4% and 27.4%, respectively, among the cases found to be positive by the faecal blood test. Accordingly, the positive predictive value of this test was calculated to be 6.4% (table 2) .
To calculate the sensitivity and the specificity of this screening test the subjects who met the above described definition of false negative cases were identified. Four false negative cases were found. Among these four cases, one case was within the first year of follow up, one case within two years, and two cases within three years (table 3) . Accordingly, the sensitivity of this test was calculated as 90.9% within the first year, 83.3% within the second year, and 71.4% within the third year, while the specificity was 95.6% (table 4) . 
Validity of immunochemical occult test
The sensmvity is also affected by the reliability of the identification of false negative cases among the subjects being screening. For an accurate estimate of the sensitivity we followed up each subject screened strictly by considering registration data as well as information from medical facilities. These registration data are often reported three months late and can be used for the identification of false negative cases within the follow up period in this study. This registry system has been estimated to register more than 90% of all patients with newly diagnosed colorectal cancer.
The positivity rate of 5% is higher than that of the Haemoccult test, and a large proportion of the screened population will have a positive result in annual screening. If this high positivity rate proves to be a limiting factor for wide scale colorectal cancer screening, then it may be necessary to reset the cut off point of the test.
In conclusion, the immunological faecal occult blood test has a high diagnostic accuracy and is a useful strategy for colorectal cancer screening. 
